The National Cancer Institute in its definition of delta-8-THC defined it as an analog of tetrahydrocannabinol (THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective property. Further clarification on the compound shows that it binds to CB1 and CB2 cannabinoid receptors located in the central nervous system. These cannabinoid receptors are G-protein coupled receptors. Upon binding to these receptors in the brain, delta-8-THC also causes a euphoric feeling though not as potent as delta-9-THC.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…